Funder
National Institute of Food and Drug Safety Evaluation
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Toxicology,Molecular Biology
Reference40 articles.
1. Adamowicz, P., Gieron, J., Gil, D., Lechowicz, W., Skulska, A., & Tokarczyk, B. (2016). The prevalence of new psychoactive substances in biological material—a three-year review of casework in Poland. Drug Testing and Analysis, 8, 63–70.
2. Mounteney, J., Griffiths, P., Sedefov, R., Noor, A., Vicente, J., & Simon, R. (2016). The drug situation in Europe: An overview of data available on illicit drugs and new psychoactive substances from European monitoring in 2015. Addiction, 111, 34–48.
3. ACMD, U.A.C.o.t.M.o.D. (2011). Consideration of the novel psychoactive substances ‘legal highs’.
4. ACMD, U.A.C.o.t.M.o.D. (2012). Advisory Council on the Misuse of Drugs, “Statement of Evidence on Methoxetamine”.
5. Wood, D. M., Davies, S., Puchnarewicz, M., Johnston, A., & Dargan, P. I. (2012). Acute toxicity associated with the recreational use of the ketamine derivative methoxetamine. European Journal of Clinical Pharmacology, 68, 853–856.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献